<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03680690</url>
  </required_header>
  <id_info>
    <org_study_id>pregnancy rate in ICSI cycles</org_study_id>
    <nct_id>NCT03680690</nct_id>
  </id_info>
  <brief_title>Pregnancy Rate in Women With Normal Uterine Cavity and Those With Corrected Uterine Lesions in ICSI Cycles</brief_title>
  <official_title>Pregnancy Rate in Women With Normal Uterine Cavity and Those With Corrected Uterine Lesions in ICSI Cycles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to investigate the pregnancy rate in women with normal
      uterine cavity and those detected or corrected uterine cavitary lesions, assessed by
      hysteroscopy in ICSI cycles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intrauterine pathology has been reported in up to 25% of infertile women having IVF treatment
      and in as many as 50% of women with recurrent implantation failure, leading to suggestions
      that correction of such pathology could improve treatment outcome. Hysteroscopy allows visual
      assessment of the cervical canal and uterine cavity and provides the opportunity to operate
      in the same setting. Routine outpatient hysteroscopy before starting IVF has been postulated
      to diagnose and treat abnormalities of the cervix and uterine cavity and hence improve IVF
      outcome.

      A systematic review of published studies suggested that outpatient hysteroscopy in the
      menstrual cycle preceding an IVF treatment cycle could significantly increase the clinical
      pregnancy rate in women who had previously had recurrent implantation failure, even when no
      hysteroscopic abnormality was detected.

      However, the result of the TROPHY study - published in the Lancet in 2016 concluded that
      Outpatient hysteroscopy before IVF in women with a normal ultrasound of the uterine cavity
      and a history of unsuccessful IVF treatment cycles does not improve the livebirth rate and
      they recommended that further research into the effectiveness of surgical correction of
      specific uterine cavity abnormalities before IVF is warranted.

      An MD thesis done in our department on the evaluation of the endometrial cavity in infertile
      patients and prior to IVF recommended that there is an urgent need to RCT to emphasize the
      benefit of removal of the detected intrauterine lesions before proceeding to IVF.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>7th week of pregnancy for cardiac pulsations.</time_frame>
    <description>Clinical pregnancy rate Will be evaluated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chemical pregnancy rate Chemical pregnancy rate</measure>
    <time_frame>4 weeks</time_frame>
    <description>Chemical pregnancy rate
Chemical pregnancy rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>6 weeks</time_frame>
    <description>Implantation rate for assessment of implanted embryos</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abortion rate</measure>
    <time_frame>up to 28 week</time_frame>
    <description>Abortion rate will be observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm labour rate</measure>
    <time_frame>9 months</time_frame>
    <description>Delivary before term 37 weeks of pregnancy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">244</enrollment>
  <condition>Intracytoplasmic Sperm Injection</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>women with normal uterus,detected by hysteroscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>Women with detected or corrected uterine cavitary lesions by hysteroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hysteroscopy</intervention_name>
    <description>office hysteroscopy will be done for all candidates and operative correction of detected lesions will be carried on.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <other_name>hysteroscopic uterine lesion detection or correction</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all infertile females will be assesed in IVF unite of women's health Hospital and will be
        recruted according to the inclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women between 18 and 38 years old.

          -  An indication for IVF/ICSI.

          -  Normal 2D transvaginal U/S assessment of the uterine cavity, or abnormal cavity
             detected by 2D ,3D and HSG.

          -  Women with primary or secondary infertility.

          -  Women with BMI between 20 &amp; 35.

        Exclusion Criteria:

          -  Refusal to join the study.

          -  Untreated tubal hydrosalpinges.

          -  Poor responders as assessed by AFC 4 or less ,AMH O.8 ng/dl (nice 2013).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>infertile females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Youssef, MD/MSC</last_name>
    <role>Study Chair</role>
    <affiliation>women's health hospital,Assiut university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ibrahim Mohammed, MD/MSc</last_name>
    <role>Study Director</role>
    <affiliation>women's health hospital,Assiut university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sayed Moustafa, MD/MSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>women's health hospital,Assiut university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Kamel, MSC/MBBh</last_name>
    <role>Principal Investigator</role>
    <affiliation>women's health hospital,Assiut university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed Kamel, MSc/Mbbh</last_name>
    <phone>00201003627020</phone>
    <email>ahmedmomen414@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Youssef, MD/Mssc/Mbbh</last_name>
    <phone>01006184921</phone>
    <email>ahmedalaa11828@yahoo.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by 'recurrent implantation failure'? A systematic review and opinion. Reprod Biomed Online. 2014 Apr;28(4):409-23. doi: 10.1016/j.rbmo.2013.12.006. Epub 2014 Jan 17. Review.</citation>
    <PMID>24581986</PMID>
  </results_reference>
  <results_reference>
    <citation>Coughlan C, Walters S, Ledger W, Li TC. A comparison of psychological stress among women with and without reproductive failure. Int J Gynaecol Obstet. 2014 Feb;124(2):143-7. doi: 10.1016/j.ijgo.2013.08.006. Epub 2013 Oct 31.</citation>
    <PMID>24290538</PMID>
  </results_reference>
  <results_reference>
    <citation>Zeyneloglu HB, Onalan G. Remedies for recurrent implantation failure. Semin Reprod Med. 2014 Jul;32(4):297-305. doi: 10.1055/s-0034-1375182. Epub 2014 Jun 11. Review.</citation>
    <PMID>24919029</PMID>
  </results_reference>
  <results_reference>
    <citation>Papathanasiou A, Bhattacharya S. Prognostic factors for IVF success: diagnostic testing and evidence-based interventions. Semin Reprod Med. 2015 Mar;33(2):65-76. doi: 10.1055/s-0035-1545364. Epub 2015 Mar 3. Review.</citation>
    <PMID>25734344</PMID>
  </results_reference>
  <results_reference>
    <citation>Moini A, Kiani K, Ghaffari F, Hosseini F. Hysteroscopic findings in patients with a history of two implantation failures following in vitro fertilization. Int J Fertil Steril. 2012 Apr;6(1):27-30. Epub 2012 Jun 19.</citation>
    <PMID>25505508</PMID>
  </results_reference>
  <results_reference>
    <citation>Cenksoy P, Ficicioglu C, Yıldırım G, Yesiladali M. Hysteroscopic findings in women with recurrent IVF failures and the effect of correction of hysteroscopic findings on subsequent pregnancy rates. Arch Gynecol Obstet. 2013 Feb;287(2):357-60. doi: 10.1007/s00404-012-2627-5. Epub 2012 Nov 27.</citation>
    <PMID>23183783</PMID>
  </results_reference>
  <results_reference>
    <citation>Dicker D, Ashkenazi J, Feldberg D, Farhi J, Shalev J, Ben-Rafael Z. The value of repeat hysteroscopic evaluation in patients with failed in vitro fertilization transfer cycles. Fertil Steril. 1992 Oct;58(4):833-5.</citation>
    <PMID>1426335</PMID>
  </results_reference>
  <results_reference>
    <citation>La Sala GB, Montanari R, Dessanti L, Cigarini C, Sartori F. The role of diagnostic hysteroscopy and endometrial biopsy in assisted reproductive technologies. Fertil Steril. 1998 Aug;70(2):378-80.</citation>
    <PMID>9696242</PMID>
  </results_reference>
  <results_reference>
    <citation>Levi Setti PE, Colombo GV, Savasi V, Bulletti C, Albani E, Ferrazzi E. Implantation failure in assisted reproduction technology and a critical approach to treatment. Ann N Y Acad Sci. 2004 Dec;1034:184-99. Review.</citation>
    <PMID>15731311</PMID>
  </results_reference>
  <results_reference>
    <citation>El-Toukhy T, Campo R, Khalaf Y, Tabanelli C, Gianaroli L, Gordts SS, Gordts S, Mestdagh G, Mardesic T, Voboril J, Marchino GL, Benedetto C, Al-Shawaf T, Sabatini L, Seed PT, Gergolet M, Grimbizis G, Harb H, Coomarasamy A. Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial. Lancet. 2016 Jun 25;387(10038):2614-2621. doi: 10.1016/S0140-6736(16)00258-0. Epub 2016 Apr 27.</citation>
    <PMID>27132053</PMID>
  </results_reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>September 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2018</study_first_posted>
  <last_update_submitted>September 20, 2018</last_update_submitted>
  <last_update_submitted_qc>September 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Momen Ahmed Mohammed Kamel</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

